Pharma News: Vivus, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA)’s Announcement & MannKind Corporation (MNKD)’s New Options

Page 1 of 2

Editor’s Note: Related tickers: VIVUS, Inc. (NASDAQ:VVUS), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), MannKind Corporation (NASDAQ:MNKD), J.C. Penney Company, Inc. (NYSE:JCP)

3 Pharmaceutical Stocks to Sell Now (InvestorPlace)
This week, the ratings of three Pharmaceutical stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”). This week, VIVUS, Inc. (NASDAQ:VVUS) falls to a D (“sell”), worse than last week’s grade of C (“hold”). VIVUS is a biopharmaceutical company engaged in the development and commercialization of therapeutic products for large underserved markets. VVUS also rates an F in Portfolio Grader’s specific subcategory of Equity. The stock price has dropped 17.4% over the past month, worse than the 1.3% decrease the Nasdaq has seen over the same period of time.

VIVUS, Inc. (NASDAQ:VVUS)

Eye Catching Stocks for Friday’s Trading Session: Arena Pharmaceuticals Inc (ARNA), J.C. Penney Company Inc (JCP) (SBWire)
Pennystocksupdate.biz issues special report on – Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), J.C. Penney Company, Inc. (NYSE:JCP) Arena Pharmaceuticals Inc (NASDAQ: ARNA) may have triggered an individual to create heart disease in an early-stage medical query, the company refers to, one day after introducing there had not been any serious adverse reactions during the research. Arena Pharmaceuticals, Inc. (ARNA) after opening at $6.55 hit a high price of $6.58 and then closed at $6.35 by declining -5.08% and on last session volume of 8.68 million shares was surprisingly lower than its average volume of 4.24 million shares.

MannKind Corp. VP Unloads $110,999.12 in Stock (MNKD) (WatchlistNews)
MannKind Corporation (NASDAQ:MNKD) VP David Thomson sold 19,204 shares of MannKind Corp. stock in a transaction that occurred on Wednesday, August 28th. The stock was sold at an average price of $5.78, for a total transaction of $110,999.12. Following the sale, the vice president now directly owns 40,082 shares in the company. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. A number of analysts have recently weighed in on MNKD shares. Analysts at MLV Capital raised their price target on shares of MannKind Corporation (NASDAQ:MNKD).

Commit To Purchase Vivus At $8, Earn 17.1% (Forbes)
Investors considering a purchase of VIVUS, Inc. (NASDAQ:VVUS) shares, but cautious about paying the going market price of $12.25/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2015 put at the $8 strike, which has a bid at the time of this writing of $1.37. Collecting that bid as the premium represents a 17.1% return against the $8 commitment, or a 12.3% annualized rate of return (at Stock Options Channel we call this the YieldBoost).

Arena Reports Closing of Phase 1b Clinical Trial for APD811; Astex Shares On Watch Following Positive Top-Line Data for SGI-0110 (HispanicBusiness)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) announced the completion of a Phase 1b clinical trial for APD811, an investigational oral prostacyclin (IP) receptor agonist intended for the treatment of pulmonary arterial hypertension (PAH). The company plans to initiate a Phase 2 clinical trial for APD811 in the first quarter of 2014. “Arena’s internal GPCR-focused efforts led to the discovery of this novel drug candidate,” said William R. Shanahan, M.D., Arena’s Senior Vice President and Chief Medical Officer…

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!